30th International Conference on Molecular Medicine


6-8 November 2025


Four Points by Sheraton Catania


Catania, Italy





Presentations Include:


The list is incomplete and will be updated periodically:



  • Adel El-Naggar - (USA) - Premalignant Head and Neck squamous epithelium: Regional and biological heterogeneity.
  •  
  • Wei Zhu - (USA) - Investigating the Neuroprotective Effects of Conjugated Linoleic Acid Against Potassium Bromate-Induced Damage.
  •    
  • Daniel Gomez – (Argentina) – Improving therapeutic strategies for triple-negative breast cancer: synergistic effects of DKC1 inhibition and paclitaxel
  •    
  • Emmanouil Karteris - (UK) - Clinical utility of liquid biopsies as diagnostic or prognostic cancer biomarkers.
  •  
  • Sandra Marmiroli - (Italy) - CAPTURE-Capivasertib and Prostate Cancer Targeting: Unraveling Resistance Elements.
  •  
  • Ayodele Alaiya - (Saudi Arabia) - Predictive Biomarkers of COVID-19 Outcomes in Immunosuppressed Renal Transplant Recipients.
  •  
  • Demetrios Spandidos - (Greece) - The cancer story and publishing in biomedical sciences.
  •  
  • Paola Poma - (Italy) - Hallmarks of acquired multi-drug resistance in cancer cells: overcoming it.
  •  
  • Stefania Stella - (Italy) - Different BCR::ABL1 Transcript Levels @ 3 and 6 Months Might Be Useful In Identifying Warning/Resistant CML Patients When Using 2G-TKIS As Frontline Treatment.
  •    
  • Filomena de Nigris - (Italy) - YY1 and PCGa copperatively regulate mitochondrial gene transcription in X9-11 translocated Renal Carcinoma.
  •  
  • Saif ur Rehman - (China) - Proteomics evaluation of villi cell
  •  
  • Irina Groisman - (France) - Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer.
  •  
  • Joo Young Kim - (South Korea) - Metformin increases apoptotic sensitivity of cisplatin in Caki cells.
  •  
  • Maria Zervou - (Greece) - Where there is endometriosis, an autoimmune disease may co-occur: Genetic aspects for the cases of SLE, PS, PsA and APS
  •  
  • Iordanis Mourouzis - (Greece) - Cilostazol promotes myogenesis and protects microvascular endothelial cells under diabetic conditions in vitro: therapeutic implications for diabetes
  •  
  • Gian Marco Leone - (Italy) - New Horizons in Oncology: The Identification of Promising Therapeutic Targets
  •  
  • Beate Köberle - (Germany) - RNA is a pro-apoptotic target of cisplatin in cancer cells
  •  
  • Walburgis Brenner - (Germany) - Influence of components of the follicular fluid on endometriosis
  •  
  • Karla Aguirre - (Mexico) - Antitumor Effect of Orally Administered Aqueous Extract of Riñonina (Ipomoea pes-caprae), Alone and in Comparison with Cisplatin, on an In Vivo Model of Triple-Negative Breast Cancer (MDA-MB-231)
  •  
  • Maitham Khajah - (Kuwait) - Lactate is a major promotor of breast cancer cell aggressiveness
  •  
  • Izabela Zawlik - (Poland) - Abnormalities of GAS5, PTEN and miR-21 expression in endometrial cancer
  •  
  • Muhammad Ajmal - (Pakistan) - Development of anticancer drugs for target specific delivery to pediatric brin tumour
  •  
  • Jérémy Laurent - (France) - Evaluation of a new administration route for tricyclo-DNA antisense oligonucleotides for the systemic treatment of neuromuscular diseases
  •    
  • Rebaz Mustafa - (Iraq) - Investigating the Role of A3H in Breast Ductal Carcinoma and its Association with miRNA-103a-2-5p.
  •    
  • Tomoki Sengiku - (Japan) - Pre-treatment serum CEA as a Novel Biomarker for Recurrence in Intermediate- and High-Risk Stage IB–IIB Cervical Cancer Treated with Radical Hysterectomy Followed by TP Chemotherapy as adjuvant chemotherapy.
  •    
  • Kyosuke Yasuda - (Japan) - Pembrolizumab/Lenvatinib Combination Therapy for Uterine Corpus Cancer: A Single-Center, Retrospective Analysis.
  •    
  • Minato Tagawa - (Japan) - Exceptional response to pembrolizumab in chemotherapy-resistant recurrent ovarian cancer patient with TMB-High : a case report.
  •    
  • Giuseppe Broggi - (Italy) - Evaluation of CDKN2A/B homozygous deletion in Central Nervous System tumors.
  •  
  • Vincenzo Fiorentino - (Italy) - A morphological signature of Megakaryocytic Activation (M-ACT) for predicting myelofibrotic evolution in Philadelphia-Negative Myeloproliferative Neoplasms
  •  
  • Valeria Zuccalà - (Italy) - Integrated immunogenomic profiling of triple-negative breast cancer reveals distinct prognostic subtypes
  •  
  • Ludovica Pepe - (Italy) - Prognostic significance of the AR, ADAR2, and PD-L1 axis in papillary urothelial carcinoma
  •  
  • Cristina Pizzimenti - (Italy) - Prognostic evaluation of morphological, immunophenotypic and radiological markers in primary central nervous system diffuse large B-cell lymphomas
  •  
  • Maria Sofia Basile - (Italy) - In silico analysis of the cerebellar transcriptomic profile in Alzheimer's disease patients and identification of novel potential therapeutic strategies
  •  
  • Chiara Capasso - (Italy) - Caulerpin as a preventive antitumor and anti-inflammatory agent in sporadic and FAP colorectal cancer
  •  
  • Valeria D'Agostino - (Italy) - Hamartomatous polyposis syndromes: role of succinate dehydrogenase (SDH) in STK11 gene regulation
  •  
  • Lucia Altucci - (Italy) - Targeting epigenome in cancer.
  •  
  • Reyhaneh Farghadani - (Malaysia) - From turmeric to therapy: how curcumin, a molecular powerhouse, is restoring apoptosis in breast cancer treatment.
  •    
  • Alessandro Lavoro – (Italy) - Targeting of DNA methylation induces MMP-9/NGAL overexpression and increased immune cell infiltration in melanoma
  •  
  • Federica Longo - (Italy) - Identification of microRNAs as potential Therapeutic Targets in Drug-Resistant Colorectal Cancer
  •  
  • Anastasia Vitale – (Italy) - c-Kit- and NF1-mutated GISTs: molecular features and therapeutic opportunities
  •  
  • Graziana Spoto – (Italy) - Identification of Dysregulated Pathways and Acquired Genetic Mutations Driving Oxaliplatin Resistance in Colorectal Cancer Organoids.
  •  
  • Concettina Fenga (Italy), Denis Vinnikov – (Kazakhstan) - Venerando Rapisarda (Italy)
  •  
  • Veronica Filetti – (Italy) – Small RNA-Seq Transcriptome Profiling of Mesothelial and Mesothelioma Cell Lines Revealed microRNA Dysregulation after Exposure to Asbestos-like Fibers
  •  
  • Federica Giambò – (Italy) – Heavy Metals: Toxicity and Renal Damage
  •  
  • Serena Matera – (Italy) – Obesity as a risk factor for worker health: evaluation of inflammatory markers in a population of healthcare workers
  •  
  • Paola Senia – (Italy) – Arsenic exposure and expression of inflammation-regulating cytokines: a study of a cohort of construction workers
  •  
  • Giuseppe Sferrazzo – (Italy) – Analysis of ROS and cytokine production in workers exposed to nickel dust inhalation
  • Francesca Vella – (Italy) – Oxidative stress and DNA damage in pesticide-exposed greenhouse workers
  • Ermanno Vitale – (Italy) – miRNA expression levels in workers exposed to asbestiform fibers: comparison of subjects exposed to Metsovo (tremolite) with those of Biancavilla (fluoro-edenite)
  •    
  • Andrzej Semczuk – (Poland) – The development of left-sited ovarian carcinosarcoma from serous tubal intraepithelial carcinoma (STIC): An immunohistochemical study with literature review
  •  
  • Silvano Sozzani – (Italy) – Inflammation and Immunity in Cancer: Mechanisms and Clinical Implications
  •  
  • Germano Orrù – (Italy) – The role of oral microbiota in the development of colorectal cancer
  •    
  • Alice Foti – (Italy) – Overcoming CDK4/6 inhibitor resistance in high-risk medulloblastoma subgroups
  •    
  • Pavol Lukáč – (Czech Republic) – Dendritic cells maturation and T-cell activation in 3D and 2D models of colon cancer
  •    
  • Dario Melita – (Italy) – Surgical debridement technique for the amorphous hand in patients with Epidermolysis Bullosa
  •    
  • Federica Colapietra – (Italy) – Terpestacin-Mediated UQCRB Inhibition Selectively Reduces Tumor Viability and Enhances Apoptosis in Thyroid Carcinoma
  •    
  • Gianluca Canettieri – (Italy) – Targeting Metabolic Remodeling in Colorectal Cancer
  •    
  • Lenka Rajsiglová – (Czech Republic) – Targeted nanocarrier-mediated enhancement of chemotherapy and immune response in colorectal cancer
  •    
  • Silvia Vivarelli – (Italy) – Transcriptional control of circadian clock genes by the transcription factor Yin Yang 1 in night shift-related breast cancer
  •    
  • Caterina Oliveri – (Italy) – Evaluating the synergistic effects of night shift work and toxicant exposure on immune health: toward evidence-based prevention strategies
  •    
  • Michele Teodoro – (Italy) – Identification of UV-induced genes involved in cutaneous melanoma pathways
  •    
  • Rodrigo D'amico – (Italy) – The consequences of CNBP reduced expression in DM2 pathogenesis.
  •    
  • Wiktoria Romańczyk – (Poland) – Nectin-1 and Nectin-3 proteins corelation with other adhesion proteins and clinical-pathological parameters.
  •    
  • Pavol Lukáč – (Czech Republic) – Dendritic cells maturation and T-cell activation in 3D and 2D models of colon cancer
  •    
  • Sabrina Tosi – (UK) – Integrated in silico and in vitro approaches identify SNX.2112 as a t(7;12) AML drug vulnerability targeting leukaemia candidate stem cells.
  •    
  • Luca Falzone – (Italy) – Integrated Genomic and Transcriptomic Profiling Reveals Mechanisms of 5-FU Resistance in Colorectal Cancer Organoids.
  •    
  • Carmen Romero – (Chile) – Effects of miR-145, miR-23b mix, and Metformin in Epithelial Ovarian Cancer Cell Spheroids.
  •    
  • Rosa Bordone – (Italy) – MYC UR regulates metastasis in colorectal cancer through non-canonical start codon selection.
  •    
  • Liam McCulney – (USA) – Occupational and Environmental Exposures: Molecular Signatures, Health Risks and Cancer Links.
  •    
  • Victor Meli – (Italy) – MicroRNA-based diagnostic and prognostic markers in malignant mesothelioma linked to environmental asbestiform fiber exposure.
  •    
  • Liam McCulney – (USA) – Occupational and Environmental Exposures: Molecular Signatures, Health Risks and Cancer Links.
  •    
  • Stefano Lucà – (Italy) – Molecular Basis and Diagnostic Implications in Pleural Mesothelioma.
  •  





    Back to Top